INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1ISRG • US46120E6023

410.85 EUR
-57.35 (-12.25%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to 1ISRG. 1ISRG was compared to 63 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG is quite expensive at the moment. It does show a decent growth rate. With these ratings, 1ISRG could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • 1ISRG had positive earnings in the past year.
  • In the past year 1ISRG had a positive cash flow from operations.
  • Of the past 5 years 1ISRG 4 years were profitable.
  • 1ISRG had a positive operating cash flow in 4 of the past 5 years.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • The Return On Assets of 1ISRG (14.19%) is better than 92.06% of its industry peers.
  • 1ISRG's Return On Equity of 16.12% is amongst the best of the industry. 1ISRG outperforms 84.13% of its industry peers.
  • 1ISRG has a better Return On Invested Capital (12.45%) than 85.71% of its industry peers.
  • 1ISRG had an Average Return On Invested Capital over the past 3 years of 10.15%. This is in line with the industry average of 9.98%.
  • The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(12.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.19%
ROE 16.12%
ROIC 12.45%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • 1ISRG has a better Profit Margin (28.58%) than 96.83% of its industry peers.
  • In the last couple of years the Profit Margin of 1ISRG has declined.
  • With an excellent Operating Margin value of 29.44%, 1ISRG belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1ISRG has declined.
  • 1ISRG has a Gross Margin of 66.38%. This is in the better half of the industry: 1ISRG outperforms 74.60% of its industry peers.
  • In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 29.44%
PM (TTM) 28.58%
GM 66.38%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.27
WACC9.78%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 4.97 indicates that 1ISRG has no problem at all paying its short term obligations.
  • 1ISRG's Current ratio of 4.97 is amongst the best of the industry. 1ISRG outperforms 95.24% of its industry peers.
  • 1ISRG has a Quick Ratio of 4.20. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of 1ISRG (4.20) is better than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 4.97
Quick Ratio 4.2
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.83% over the past year.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.07% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 12.31% on average over the next years. This is quite good.
EPS Next Y11.25%
EPS Next 2Y13.22%
EPS Next 3Y13.64%
EPS Next 5Y15.07%
Revenue Next Year15.2%
Revenue Next 2Y14.36%
Revenue Next 3Y13.92%
Revenue Next 5Y12.31%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 54.27, which means the current valuation is very expensive for 1ISRG.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 60.32% of the companies listed in the same industry.
  • 1ISRG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.93.
  • Based on the Price/Forward Earnings ratio of 48.77, the valuation of 1ISRG can be described as expensive.
  • 1ISRG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 71.43% of the companies in the same industry.
  • 1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 27.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 54.27
Fwd PE 48.77
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • 1ISRG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 75.63
EV/EBITDA 47.36
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1ISRG has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 13.64% in the coming years.
PEG (NY)4.82
PEG (5Y)2.53
EPS Next 2Y13.22%
EPS Next 3Y13.64%

0

5. Dividend

5.1 Amount

  • No dividends for 1ISRG!.
Industry RankSector Rank
Dividend Yield 0%

INTUITIVE SURGICAL INC

BIT:1ISRG (2/5/2026, 7:00:00 PM)

410.85

-57.35 (-12.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-20
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap145.65B
Revenue(TTM)N/A
Net Income(TTM)2.75B
Analysts77
Price Target530.96 (29.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.86%
PT rev (3m)3.44%
EPS NQ rev (1m)0.91%
EPS NQ rev (3m)4.18%
EPS NY rev (1m)0.37%
EPS NY rev (3m)6.06%
Revenue NQ rev (1m)1.08%
Revenue NQ rev (3m)2.75%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)1.59%
Valuation
Industry RankSector Rank
PE 54.27
Fwd PE 48.77
P/S 17.87
P/FCF 75.63
P/OCF 58.02
P/B 10.08
P/tB 10.29
EV/EBITDA 47.36
EPS(TTM)7.57
EY1.84%
EPS(NY)8.42
Fwd EY2.05%
FCF(TTM)5.43
FCFY1.32%
OCF(TTM)7.08
OCFY1.72%
SpS22.99
BVpS40.76
TBVpS39.93
PEG (NY)4.82
PEG (5Y)2.53
Graham Number83.32
Profitability
Industry RankSector Rank
ROA 14.19%
ROE 16.12%
ROCE 16.61%
ROIC 12.45%
ROICexc 24.65%
ROICexgc 25.69%
OM 29.44%
PM (TTM) 28.58%
GM 66.38%
FCFM 23.63%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 111.36%
Cap/Sales 7.17%
Interest Coverage 250
Cash Conversion 85.84%
Profit Quality 82.69%
Current Ratio 4.97
Quick Ratio 4.2
Altman-Z N/A
F-Score8
WACC9.78%
ROIC/WACC1.27
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y11.25%
EPS Next 2Y13.22%
EPS Next 3Y13.64%
EPS Next 5Y15.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.76%
Revenue Next Year15.2%
Revenue Next 2Y14.36%
Revenue Next 3Y13.92%
Revenue Next 5Y12.31%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year46.47%
EBIT Next 3Y24.63%
EBIT Next 5Y20.85%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%

INTUITIVE SURGICAL INC / 1ISRG.MI FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 5 / 10 to 1ISRG.MI.


What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.


Can you provide the profitability details for INTUITIVE SURGICAL INC?

INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for 1ISRG stock?

The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 54.27 and the Price/Book (PB) ratio is 10.08.


Can you provide the financial health for 1ISRG stock?

The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.